Crossref
Eribulin mesylate: A new therapeutic option for metastatic breast cancer
Journal of Basic and Clinical Reproductive Sciences · 2013
DOI: 10.4103/2278-960x.112571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Reproductive Sciences, 2013. Verfasst von Suruchi Aditya. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aditya, S. (2013). Eribulin mesylate: A new therapeutic option for metastatic breast cancer. Journal of Basic and Clinical Reproductive Sciences. https://doi.org/10.4103/2278-960x.112571
Vancouver
Aditya S. Eribulin mesylate: A new therapeutic option for metastatic breast cancer. Journal of Basic and Clinical Reproductive Sciences. 2013. doi:10.4103/2278-960x.112571
BibTeX
@article{Aditya2013,
author = {Aditya, Suruchi},
title = {Eribulin mesylate: A new therapeutic option for metastatic breast cancer},
journal = {Journal of Basic and Clinical Reproductive Sciences},
year = {2013},
doi = {10.4103/2278-960x.112571}
}
EUVIMED